Target intelligence / Profile preview

Immunoglobulin superfamily member 21 pseudogene

Molecular classification: Pseudogene, Other

Overview

Immunoglobulin superfamily member 21 pseudogene" (ENSG00000254783, LOC100289518) is a non-functional copy of the Immunoglobulin superfamily member 21 gene. It does not encode a protein, and there is no evidence it functions as a receptor, enzyme, or drug target. It has no known role in biology or disease, and it is not used as a biomarker or involved in safety/therapeutic considerations as an active target[4]. This designation is correct as a pseudogene, and is not applicable for drug discovery or therapeutic targeting.

Other names: LOC100289518IGSF21 pseudogeneImmunoglobulin superfamily, member 21 pseudogene

Beyond the preview

Go deeper on Immunoglobulin superfamily member 21 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin superfamily member 21 pseudogene.

Explore the full profile